Tuesday, October 14, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Microscopic packets could deliver diabetes-preventing therapeutics

August 14, 2024
in Cancer
Reading Time: 3 mins read
0
66
SHARES
596
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Within each of us lies an army of cells whose topmost duty is protecting against external pathogens and internal threats such as proliferating cancer cells. Yet, immune cells can sometimes erroneously attack the body, causing autoimmune diseases like type 1 diabetes.

Within each of us lies an army of cells whose topmost duty is protecting against external pathogens and internal threats such as proliferating cancer cells. Yet, immune cells can sometimes erroneously attack the body, causing autoimmune diseases like type 1 diabetes.

Texas A&M researchers recently received an RO1 grant from the National Institutes of Health to develop a strategy to deliver immune-suppressing proteins generally produced by specialized stem cells. Such an approach could potentially help reduce the immune system’s attack on the insulin-producing beta-cells in the pancreas and open doors to a novel treatment for type 1 diabetes.

“We are excited that the NIH will be supporting us in our research in this area, which has implications for not just type 1 diabetes but also other autoimmune diseases,” said Dr. Roland Kaunas, associate professor in the biomedical engineering department and a grant award recipient.

According to the National Diabetes Statistics Report, 35 per 10,000 youths in the United States have diabetes, of which 304,000 have type 1 diabetes. Currently, the only approved treatment for the condition is lifelong insulin therapy. However, there is ongoing research investigating new therapeutics and approaches to treating this and other autoimmune diseases. For example, cell-based therapies, wherein immune cells or stem cells are genetically altered to produce immune-suppressing products, are an area of active investigation. However, these interventions have challenges, such as toxicity and difficulty transplanting gene-edited cells.

“Mesenchymal stem cells are valuable as a therapy because they can dampen the immune response, but as of now, they are not FDA approved,” said Kaunas. “This is a strong motivation for developing cell-free versions of stem cell therapies that could represent a lower hurdle to getting approval by the FDA.”

TAMU researchers thus focused on techniques to deliver therapeutic products produced by stem cells rather than the cells themselves. So, for example, mesenchymal stem cells (MSCs), like any other cell in the body, produce tiny, nanosized cargo-carrying packets, called extracellular vesicles, that contain RNA, DNA, and other proteins. Some of the proteins within the extracellular vesicles include cytokines and chemokines that can dial down immune activity. Dr. Ryang Hwa Lee, the principal investigator on this grant and associate professor at the Texas A&M School of Medicine, has previously demonstrated the therapeutic potential of MSCs and extracellular vesicles produced by MSCs in preclinical models. 

Now, Lee and Kaunas are investigating if extracellular vesicles can be engineered to deliver additional immune-suppressing proteins to more effectively prevent the immune system’s destruction of insulin-producing beta-cells. Then, they plan to demonstrate whether the engineered extracellular vesicles can prevent or even reverse the onset of type 1 diabetes. Last, the team will examine the synergistic effect of the engineered EVs and existing immune therapies in suppressing the immune system.

“We hope that our research will lead to an additional therapeutic avenue that can improve the efficacy and safety of existing immune therapy for type 1 diabetes,” said Lee. “Although ours is preclinical work, its success will facilitate the development of robust and ready-to-use extracellular vesicle-based therapeutics for type 1 diabetes and other autoimmune diseases.”

###



Share26Tweet17
Previous Post

New brain-computer interface allows man with ALS to ‘speak’ again

Next Post

International study detects consciousness in unresponsive patients

Related Posts

Cancer

Timing of Chemo Affects Survival in Elderly

October 14, 2025
blank
Cancer

HALP Score Predicts Digestive Cancer Outcomes

October 14, 2025
blank
Cancer

Myosteatosis Links Advanced Cancer in Young Women

October 14, 2025
blank
Cancer

Allostatic Load Links to Kidney Cancer Risk

October 14, 2025
blank
Cancer

Scientists Investigate Incorporating Stress Management into Cancer Treatment Beyond Conventional Methods

October 14, 2025
blank
Cancer

Innovative Imaging Technique Shows Promise in Boosting Survival Rates for Patients with Recurrent Prostate Cancer

October 14, 2025
Next Post

International study detects consciousness in unresponsive patients

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27567 shares
    Share 11024 Tweet 6890
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    974 shares
    Share 390 Tweet 244
  • Bee body mass, pathogens and local climate influence heat tolerance

    647 shares
    Share 259 Tweet 162
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    515 shares
    Share 206 Tweet 129
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    482 shares
    Share 193 Tweet 121
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Timing of Chemo Affects Survival in Elderly
  • Innovative Mindlin Model Predicts Shallow Shield Tunnel Settlement
  • New Scale Measures Symptom Severity in Older Patients
  • Evaluating Albendazole Quality in Nepal’s Veterinary Pharmacies

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,191 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading